Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem J
2001 Jan 15;353Pt 2:387-93. doi: 10.1042/0264-6021:3530387.
Show Gene links
Show Anatomy links
Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2.
Yao SY
,
Sundaram M
,
Chomey EG
,
Cass CE
,
Baldwin SA
,
Young JD
.
???displayArticle.abstract???
The human and rat equilibrative nucleoside transporter proteins hENT1, rENT1, hENT2 and rENT2 belong to a family of integral membrane proteins with 11 potential transmembrane segments (TMs), and are distinguished functionally by differences in transport of nucleobases and sensitivity to inhibition by nitrobenzylthioinosine (NBMPR) and vasoactive drugs. In the present study, we have produced recombinant hENT1, rENT1, hENT2 and rENT2 in Xenopus oocytes and investigated uridine transport following exposure to the impermeant thiol-reactive reagent p-chloromercuriphenyl sulphonate (PCMBS). PCMBS caused reversible inhibition of uridine influx by rENT2, but had no effect on hENT1, hENT2 or rENT1. This difference correlated with the presence in rENT2 of a unique Cys residue (Cys(140)) in the outer half of TM4 that was absent from the other ENTs. Mutation of Cys(140) to Ser produced a functional protein (rENT2/C140S) that was insensitive to inhibition by PCMBS, identifying Cys(140) as the exofacial Cys residue in rENT2 responsible for PCMBS inhibition. Uridine protected wild-type rENT2 against PCMBS inhibition, suggesting that Cys(140) in TM4 lies within or is closely adjacent to the substrate-translocation channel of the transporter. TM4 has been shown previously to be within a structural domain (TMs 3-6) responsible for interactions with NBMPR, vasoactive drugs and nucleobases.
Agbanyo,
External location of sites on pig erythrocyte membranes that bind nitrobenzylthioinosine.
1988, Pubmed
Agbanyo,
External location of sites on pig erythrocyte membranes that bind nitrobenzylthioinosine.
1988,
Pubmed
Baldwin,
Nucleoside transporters: molecular biology and implications for therapeutic development.
1999,
Pubmed
Che,
Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotransporter.
1995,
Pubmed
Crawford,
Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
1998,
Pubmed
Fredholm,
Adenosine and neuroprotection.
1997,
Pubmed
Griffiths,
Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.
1997,
Pubmed
,
Xenbase
Griffiths,
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
1997,
Pubmed
,
Xenbase
Huang,
Functional expression of Na(+)-dependent nucleoside transport systems of rat intestine in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system N1 (cif) and a second, novel system N3 having broad specificity for purine and pyrimidine nucleosides.
1993,
Pubmed
,
Xenbase
Huang,
Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein.
1994,
Pubmed
,
Xenbase
Jarvis,
Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter.
1982,
Pubmed
Jarvis,
Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
1986,
Pubmed
Jarvis,
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.
1982,
Pubmed
Jarvis,
Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate.
1986,
Pubmed
Kwong,
Mammalian nitrobenzylthioinosine-sensitive nucleoside transport proteins. Immunological evidence that transporters differing in size and inhibitor specificity share sequence homology.
1992,
Pubmed
Kwong,
Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters.
1993,
Pubmed
Mackey,
Nucleoside transport and its significance for anticancer drug resistance.
1998,
Pubmed
Ritzel,
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
1998,
Pubmed
,
Xenbase
Ritzel,
Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1).
1997,
Pubmed
,
Xenbase
Sarkar,
The "megaprimer" method of site-directed mutagenesis.
1990,
Pubmed
Shryock,
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
1997,
Pubmed
Sundaram,
Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.
1998,
Pubmed
,
Xenbase
Tse,
Evidence for the asymmetrical binding of p-chloromercuriphenyl sulphonate to the human erythrocyte nucleoside transporter.
1985,
Pubmed
Vickers,
Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).
1999,
Pubmed
Wang,
Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization.
1997,
Pubmed
,
Xenbase
Yao,
Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes.
1996,
Pubmed
,
Xenbase
Yao,
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
1997,
Pubmed
,
Xenbase
